Skip to main content
SpringerLink
Log in

Apixaban/factor-VIII-inhibitor-bypassing-fraction/rivaroxaban

Intracranial haemorrhage and lack of efficacy following off-label use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sheikh-Taha M, et al. Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding. Clinical Drug Investigation 43 : 883-888, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1007/s40261-023-01316-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Apixaban/factor-VIII-inhibitor-bypassing-fraction/rivaroxaban. Reactions Weekly 1993, 32 (2024). https://doi.org/10.1007/s40278-024-52955-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52955-x

Search

Navigation